New-Onset Type 1 Diabetes in Children With SARS-CoV-2 Infection

Area of Science:

• Pediatrics
• Endocrinology
• Infectious Diseases

Background:

• The COVID-19 pandemic correlates with increased diabetic ketoacidosis (DKA) in pediatric patients.
• Infections are known DKA triggers in children with existing diabetes mellitus.
• The role of SARS-CoV-2 in triggering new-onset diabetes and DKA in previously healthy children is under-explored.

Observation:

• This case report details two pediatric patients presenting with DKA and concurrent SARS-CoV-2 infection.
• Neither child had a prior diagnosis of diabetes mellitus.
• The findings suggest a potential link between SARS-CoV-2 infection and new-onset diabetes in children.

Findings:

• SARS-CoV-2 infection may act as a trigger for new-onset diabetes mellitus and DKA in the pediatric population.
• The study highlights the importance of considering SARS-CoV-2 as a potential cause of new-onset diabetes in children presenting with DKA.
• Further research is warranted to confirm the association and understand the underlying mechanisms.

Implications:

• These findings underscore the need for increased vigilance among healthcare providers regarding new-onset diabetes in children during the SARS-CoV-2 pandemic.
• Early recognition and management of DKA in children with concurrent SARS-CoV-2 infection are crucial.
• This research contributes to understanding the broader metabolic impacts of SARS-CoV-2 infection in pediatric populations.